Loading
Latest filing published 22 Jun 2018 for Crescita Therapeutics Inc., €3,171.
No signal scores available.
Wade Hull is a declared insider of Crescita Therapeutics Inc., with filings sourced from SEDI. The record holds 2 filings, for trades running from 16 May 2016 to 15 June 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 22 June 2018: an option exercise of €3,171, in Crescita Therapeutics Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.